Judges block Arkansas from carrying out scheduled executions – Washington Post

The eight inmates originally scheduled to be executed in Arkansas this month. (Arkansas Department of Corrections/AFP via Getty Images)

Two judges issued separate orders temporarily blocking Arkansas from carrying out a series of executions scheduled to begin next week, throwing into question whether the state would be able to carry out some or any of the lethal injections as planned.

In the first ruling, an Arkansas circuit judge on Friday evening issued an order temporarily blocking the state from using one of its lethal injection drugs until further notice following a complaint from a drug distributor. On Saturday morning, a federal judge followed suit, issuing a preliminary order staying the executions in response to a lawsuit mounted by the death-row inmates.

State officials challenged one order Saturday and vowed to fight the other. The mounting legal fight adds further uncertainty to a situation that had recently made Arkansas the epicenter of the country’s debate over the death penalty. The state’s original plan to execute eight inmates over 11 days, an unprecedented schedule, has prompted criticism from former corrections officials and drawn national attention. Arkansas has said this scheduled is needed because one of its lethal drugs will expire at the end of the month.

[Drug companies take aim at Arkansas executions and demand lethal injection drugs back]

The circuit judge’s ruling Friday evening came a day after drug companies began taking aim at Arkansas for its upcoming executions, arguing that the state had improperly obtained their drugs for use in lethal injections. McKesson, a drug distributor, said Arkansas misled them about why they were buying the drug, promised to give the drug back after being issued a refund and then refused to return it; state officials initially declined to comment on those claims Friday.

McKesson filed a complaint over the drug in state court. The circuit judge then barred Arkansas officials from using that drug, one of the three chemicals the state planned to use in lethal injections, which effectively prohibits them from carrying out the executions as planned. Arkansas officials on Saturday challenged this order at the state Supreme Court, dismissing the company’s demand that they return the drug and arguing that “McKesson willingly sold a drug to the [Arkansas Department of Corrections] and then experienced seller’s remorse.”

The executions in Arkansas were scheduled to begin Monday evening with two back-to-back lethal injections, with double executions following on three other nights. All of the inmates are men, and all were convicted of capital murder. Court orders have already delayed two of the planned executions, including an Arkansas Supreme Court order on Friday afternoon that stayed one of the lethal injections planned for Monday.

Arkansas plans to execute seven inmates in 11 days starting on April 17, an unprecedented schedule set before their supply of a controversial drug expires at the end of the month. Defense lawyer Jeff Rozensweig said the execution schedule “reeks of an assembly line.” (Reuters)

The death-row inmates and others not facing imminent execution have also argued in a federal lawsuit that the state’s execution schedule and protocol are unconstitutional. In a federal order issued early Saturday, U.S. District Judge Kristine G. Baker wrote that she was “compelled to stay these executions” following a series of hearings this week, determining that under the Arkansas execution policy, inmates would not have enough access to their attorneys.

Baker wrote that if one attorney is permitted to witness the execution but must leave to petition a court, this would leave the inmate facing execution without counsel. She issued a preliminary injunction order blocking Arkansas from carrying out the scheduled executions with the state’s current viewing policies in place. Baker also wrote that “there is a significant possibility” the death-row inmates could succeed in challenging the Arkansas lethal injection procedure as unconstitutional.

In a separate order, Baker said she concluded that the Arkansas “execution protocol interferes with the plaintiffs’ right of access to the courts.”

Baker ordered Arkansas officials to present “an appropriately tailored viewing policy” by noon Monday, just seven hours before the first scheduled execution. Arkansas Attorney General Leslie Rutledge (R), who backs capital punishment, pledged to challenge Baker’s order at the circuit court; the state filed a notice of appeal Saturday morning.

“It is unfortunate that a U.S. District Judge has chosen to side with the convicted prisoners in one of their many last-minute attempts to delay justice,” Judd Deere, a spokesman for Rutledge, said in a statement.

John C. Williams, an assistant federal public defender representing some of the inmates, praised Baker’s ruling and said the execution plans in Arkansas “denies prisoners their right to be free from the risk of torture.”

Drug companies joined the debate over the executions earlier this week, with two pharmaceutical companies on Thursday asking a federal court to keep the state from using their drugs, believed to be a sedative and a drug meant to stop the heart, in the upcoming executions.

Other companies also weighed in. The pharmaceutical giant Pfizer, which prohibits the use of its drugs in executions, said Thursday that McKesson, acting as a distributor, had sold one of its products to the Arkansas Department of Corrections “in direct violation of our policy.” Pfizer said it had twice asked Arkansas to return the drugs and had considered legal action.

[With lethal injection drugs expiring, Arkansas plans unprecedented seven executions in 11 days]

McKesson said the Arkansas Department of Corrections “intentionally sought to circumvent McKesson’s policies” by claiming that the drug it obtained — vecuronium bromide, a paralytic used in lethal injections — would only be used for medical reasons in a health facility.

According to the company, the state obtained 10 boxes of the drug in 2016. After learning it would be used in a lethal injection, McKesson said it “requested and was assured by that the product would be returned.”

A full refund was issued to Arkansas last fall, Kristin Hunter, a company spokeswoman, told The Washington Post. But because the company had still not received the drug as of Friday, Hunter said it was reviewing legal options. Later Friday, the company filed a petition in state court seeking to keep Arkansas from using the drug and outlining what it described as the state’s reversal on returning the drugs.

On Friday afternoon, Judge Wendell Griffen of the Pulaski County Circuit Court issued a temporary restraining order prohibiting state officials from using the vecuronium bromide. Griffen wrote that McKesson would suffer “loss of property and forced participation in a procedure that is likely to cause reputational injury” if he did not act.

Griffen wrote that these issues could not be remedied later, while the state could later obtain a replacement drug.

State officials have previously questioned that they could easily replace their drugs. A shortage of lethal injection drugs has caused states nationwide to scramble in recent years, and Arkansas officials have pointed to this shortage in arguing for the executions scheduled this month. They said that one of their three lethal injection drugs — midazolam, a controversial sedative — will expire at the end of the month, and they are not sure if more can be obtained.

If Griffen’s order remains in place, it would essentially stay all of the scheduled executions, state officials said in court filings challenging it Saturday. They said that the Arkansas Department of Corrections has been unable to locate more of the vecuronium bromide needed as part of its three-drug protocol, and said that if they cannot use the drug obtained from McKesson, “then the executions cannot go forward.”

In his order, Griffen prohibited Arkansas from using the paralytic drug and said he would address its future ownership at a later hearing. He also said that if state officials objected, they were welcome to appear on Tuesday morning — a day after the first scheduled execution — or could make an application for an earlier hearing.

“We are pleased that the court has ruled in our favor and we look forward to the return of our product,” McKesson said in a statement.

The Department of Corrections had declined to comment on McKesson’s statements earlier Friday, and a spokesman declined Friday evening to comment on Griffen’s order because of pending litigation in the case. But in a court filing Saturday, Arkansas officials rejected the company’s claims and argued that McKesson’s public association with the executions is solely because the company issued statements and filed a lawsuit.

Griffen’s order was issued the same day he was reported to be among those demonstrating at a vigil related to the executions, which state officials seized on in their challenge. Rutledge, the state’s attorney general, filed an appeal Saturday with the Arkansas Supreme Court seeking to have Griffen’s order vacated and have him removed from the case.

“As a public opponent of capital punishment, Judge Griffen should have recused himself from this case,” Deere, the spokesman for Rutledge, said in a statement.

The first of the six remaining executions was scheduled to take place Monday evening, and the last was scheduled for April 27.

Further reading:

How lethal injections have changed over the past decade

After divided Supreme Court allows Alabama execution, inmate heaves and coughs during lethal injection

A guide to the drugs used in lethal injections

This story, first published Friday night after the circuit court order, has been updated on Saturday morning with the federal order and the state’s challenge. 

Let’s block ads! (Why?)

Bookmark the permalink.